MedPage Today on MSN
Prior Biologic Use Tied to JAK Inhibitor Benefit in Ulcerative Colitis
In certain patients, JAK inhibitor rescue medications seem to be more effective, researche ...
LA JOLLA, Calif.--(BUSINESS WIRE)--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results